Camoni Laura, Raimondo Mariangela, Dorrucci Maria, Regine Vincenza, Salfa Maria Cristina, Suligoi Barbara
Department of Infectious Diseases, Istituto Superiore di Sanità , Rome, Italy .
AIDS Res Hum Retroviruses. 2015 Mar;31(3):282-7. doi: 10.1089/AID.2014.0154. Epub 2015 Jan 6.
In 2012, we conducted a retrospective cross-sectional study to assess the number of people living with HIV linked to care and, among these, the number of people on antiretroviral therapy. The health authority in each of the 20 Italian Regions provided the list of Public Infectious Diseases Clinics providing antiretroviral therapy and monitoring people with HIV infection. We asked every Public Infectious Diseases Clinic to report the number of HIV-positive people diagnosed and linked to care and the number of those on antiretroviral therapy during 2012. In 2012, 94,146 people diagnosed with HIV and linked to care were reported. The majority were males (70.1%), Italians (84.4%), and aged between 25 and 49 years (63.4%); the probable route of transmission was heterosexual contact in 37.5% of cases, injecting drug use in 28.1%, and male-to-male contact in 27.9%. Among people in care, 20.1% had less than 350 CD4 cells/μl, 87.6% received antiretroviral therapy, and among these, 62.4% had a CD4 cell count higher than 350 cells/μl. The overall estimated prevalence of individuals diagnosed and linked to care in 2012 in Italy was 0.16 per 100 residents (all ages). Adding the estimated proportion of undiagnosed people, the estimated HIV prevalence would range between 0.19 and 0.26 per 100 residents. In Italy, the majority of people diagnosed and linked to care receive antiretroviral therapy. A higher prevalence of individuals diagnosed and linked to care was observed in Northern Italy and among males. More information for developing the HIV care continuum is necessary to improve the entire engagement in care, focusing on test-and-treat strategies to substantially reduce the proportion of people still undiagnosed or with a detectable viral load.
2012年,我们开展了一项回顾性横断面研究,以评估接受治疗的艾滋病毒感染者人数,以及其中接受抗逆转录病毒治疗的人数。意大利20个大区的卫生当局提供了提供抗逆转录病毒治疗并监测艾滋病毒感染者的公共传染病诊所名单。我们要求每个公共传染病诊所报告2012年诊断出并接受治疗的艾滋病毒阳性者人数以及接受抗逆转录病毒治疗的人数。2012年,报告了94146名诊断出艾滋病毒并接受治疗的人。大多数为男性(70.1%)、意大利人(84.4%),年龄在25至49岁之间(63.4%);可能的传播途径为异性接触的占37.5%,注射吸毒的占28.1%,男男性接触的占27.9%。在接受治疗的人群中,20.1%的人的CD4细胞计数低于350个/微升,87.6%的人接受了抗逆转录病毒治疗,其中62.4%的人的CD4细胞计数高于350个/微升。2012年意大利诊断出并接受治疗的个体的总体估计患病率为每100名居民(所有年龄段)中有0.16例。加上未诊断出的人群的估计比例,艾滋病毒估计患病率在每100名居民中有0.19至0.26例之间。在意大利,大多数诊断出并接受治疗的人接受了抗逆转录病毒治疗。在意大利北部和男性中观察到诊断出并接受治疗的个体患病率较高。有必要获取更多信息以完善艾滋病毒治疗连续统一体,从而改善整个治疗参与情况,重点关注检测与治疗策略,以大幅降低仍未被诊断或病毒载量可检测到的人群比例。